AzTrials
AzTrials

Delirium - PostoperativeNCT07463586

Cerebral Oxygen Consumption Response to Increased Oxygen Supply and Postoperative Delirium in Older Surgical Patients

An observational study of Delirium - Postoperative and Cerebral Oxygenation, run by Seoul National University Bundang Hospital at 1 site in South Korea.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to learn whether the brain's ability to use oxygen during surgery is associated with postoperative delirium in adults aged 65 years and older undergoing general anesthesia. Read more about this study

Who is it for?
Ages 65 years and older
What is being tested?
Intraoperative Cerebral Oxygen Utilization Assessment
How many people
80 participants
Where
1 siteSouth Korea
Study dates
11 Mar 2026to May 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Older adult

Study population: Participants will be recruited from patients scheduled for elective laparoscopic surgery at Seoul National University Bundang Hospital, a tertiary academic medical center in the Republic of Korea. Eligible patients will be identified during routine preoperative evaluation and approached for study participation prior to surgery.

Who may be able to join

  • Patients undergoing elective laparoscopic surgery under general anesthesia
  • Age 65 years or older

Who cannot join

  • Diagnosis of dementia or presence of delirium before surgery
  • Loss of capacity to provide informed consent
  • Moderate or severe cerebrovascular stenosis diagnosed before surgery
  • Moderate or severe obstructive or restrictive pulmonary dysfunction identified on preoperative pulmonary function testing
  • Requirement for supplemental oxygen therapy before surgery
  • History of neurological disorders (e.g., Parkinson's disease, stroke) or prior brain surgery
Show all 12Show fewer
  • Severe hepatic dysfunction (AST or ALT > 120 IU/L)
  • Severe renal dysfunction (estimated GFR < 15 mL/min/1.73 m²)
  • Persistent severe hemodynamic instability (mean arterial pressure < 60 mmHg)
  • Skin conditions preventing placement of the forehead fNIRS sensor
  • Combined surgical procedures performed concurrently
  • Planned postoperative admission to the intensive care unit

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Soowon Lee, MD, PhD contact

+82-31-787-7499

soowonlee@snubh.org

South Korea1 site, 1 recruiting
  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do, 13620

    Soowon Lee, MD, PhD, +82-31-787-7499, soowonlee@snubh.org

    Recruiting

Other trials in South Korea

About this study

Official title: Association Between Cerebral Oxygen Consumption Responsiveness to Increased Oxygen Supply and Postoperative Delirium: A Prospective Observational Study Using Functional Near-Infrared Spectroscopy

The goal of this observational study is to learn whether the brain's ability to use oxygen during surgery is associated with postoperative delirium in adults aged 65 years and older undergoing general anesthesia.

The main question it aims to answer is:

  • Does reduced cerebral oxygen consumption responsiveness during surgery increase the risk of postoperative delirium in older patients?

Participants who are undergoing elective laparoscopic surgery under general anesthesia as part of their routine medical care will have brain oxygen levels measured during surgery using a non-invasive forehead sensor, and will be assessed for delirium for up to three days after surgery.

Being tested
Intraoperative Cerebral Oxygen Utilization Assessment
Medical subject headings
Emergence Delirium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intraoperative Cerebral Oxygen Utilization AssessmentOther

    Cerebral oxygenation will be monitored intraoperatively using a non-invasive forehead sensor based on functional near-infrared spectroscopy technology. During general anesthesia, the fraction of inspired oxygen (FiO₂) may be temporarily adjusted within the standard clinical range used in routine anesthesia care to evaluate the brain's oxygen utilization response. No experimental oxygen levels or additional therapeutic interventions will be administered beyond standard clinical practice.

Study groups in NCT07463586
Study groupRoleWhat they receive
Older patients undergoing elective laparoscopic surgeryAdults aged 65 years and older undergoing elective laparoscopic surgery under general anesthesia will be prospectively observed. During surgery, cerebral oxygen levels will be measured using a non-invasive forehead sensor to assess the brain's oxygen utilization response within the range of routine anesthesia care. Participants will be followed for up to three days after surgery to evaluate the occurrence of postoperative delirium.
Receives: Other: Intraoperative Cerebral Oxygen Utilization Assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of Postoperative Delirium

    Postoperative delirium diagnosed using 3D-CAM conducted in the post-anesthesia care unit and hospital ward. Delirium will be defined as at least one positive assessment during the first three postoperative days.

    Measured: Up to 3 days after surgery

Secondary outcomes (1)
  1. Intraoperative Cerebral Oxygen Utilization Response (ΔHbO-HbR)

    Change in the difference between oxygenated hemoglobin (HbO) and deoxygenated hemoglobin (HbR), calculated as Δ(HbO-HbR), measured intraoperatively using functional near-infrared spectroscopy during variations in inspired oxygen concentration within the clinically applied range.

    Measured: During surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Mar 2026
  2. Study start11 Mar 2026
  3. Primary completionMar 2028 (estimated)
  4. Study completionMay 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07463586
Sponsor's protocol ID
B-2602-1024-002
Status last verified
Mar 2026
First submitted
3 Mar 2026
Last updated
2 Apr 2026
Results posted
No
Data monitoring committee
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Delirium - Postoperative and Cerebral Oxygenation, run by Seoul National University Bundang Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Soowon Lee, MD, PhD (+82-31-787-7499, soowonlee@snubh.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of Postoperative Delirium (time frame: Up to 3 days after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2026; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in